HOME Press Releases Endoscopy Equipment Market worth 34.82 Billion USD by 2022



Endoscopy Equipment Market worth 34.82 Billion USD by 2022


The report "Endoscopy Equipment Market by Product (Endoscope (Flexible, Rigid, Capsule) Visualization Systems, Endoscopic Ultrasound, Insufflator)), Application (GI Endoscopy, Laparoscopy, Cystoscopy, Bronchoscopy, Colonoscopy, Arthroscopy) - Global Forecast to 2022", The global endoscopy equipment market is projected to reach USD 34.82 Billion by 2022 from an estimated USD 25.58 Billion in 2017, at a CAGR of 6.4% during the forecast period. The key factors driving the growth of this market include favorable government initiatives, rising number of hospitals and growing hospital investments in endoscopy facilities, technological advancements, and rising prevalence of diseases that require endoscopy.

                                                Request Sample                 Request Sample

Browse 538 market data Tables and 52 Figures spread through 432 Pages and in-depth TOC on "Endoscopy Equipment Market by Product (Endoscope (Flexible, Rigid, Capsule) Visualization Systems, Endoscopic Ultrasound, Insufflator)), Application (GI Endoscopy, Laparoscopy, Cystoscopy, Bronchoscopy, Colonoscopy, Arthroscopy) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/endoscopy-devices-market-689.html
Early buyers will receive 10% customization on reports.

By product, the endoscopes segment is expected to account for the largest share of the market in 2017

On the basis of product, the endoscopy equipment market is segmented into endoscopes, visualization equipment, other endoscopy equipment, and accessories. In 2017, the endoscopes segment is expected to account for the largest share of the global market. The large share of this segment can be primarily attributed to rising adoption of minimally invasive procedures, increasing technological advancements, and disposable endoscopes along with the corresponding need to repeat the purchase of single-use products.

By application, the GI endoscopy segment is estimated to dominate the market in 2017

Based on application, the market is segmented into laparoscopy, gastrointestinal endoscopy, arthroscopy, obstetrics/gynecology endoscopy, urology, bronchoscopy, mediastinoscopy, otoscopy, laryngoscopy, and other applications (endoscopies for facelifts, forehead lifts, abdominoplasty procedures, and breast augmentation). GI endoscopy applications are expected to command the largest share of the endoscopy equipment market in 2017. The large share of this segment can be attributed to the rising geriatric population, improving healthcare infrastructure in developing countries, and the increasing number of colonoscopy procedures performed in developed countries.

Hospitals are expected to hold the largest market share in 2017

Based on end users, the market is segmented into hospitals, ambulatory surgical centers (ASCs)/clinics, and other end users (diagnostic centers, mobile endoscopy facilities, and office endoscopy services). The hospitals segment is expected to command the largest share of the endoscopy equipment market in 2017. The large share of this segment can be attributed to increasing government and private funding and the growing preference among physicians and patients to perform endoscopic procedures in a hospital-based environment.

North America to dominate the market in 2017

In 2017, North America is expected to account for the largest share of the endoscopy equipment market, followed by Europe. Factors such as a favorable reimbursement scenario in the US, rising incidence of cancer, increasing investments by hospitals to purchase new endoscopic equipment, increasing research activities to improve endoscopy, and implementation of a new funding model for Canadian hospitals are contributing to the large share of North America.

The key players in the global endoscopy equipment market are Olympus (Japan), KARL STORZ (Germany), Stryker (US), Boston Scientific (US), Ethicon (US), Fujifilm (Japan), Medtronic (Ireland), Hoya (Japan), CONMED (US), Richard Wolf GmbH (Germany), Smith & Nephew (UK), Cook Medical (US), Cogentix Medical (US), and B. Braun (Germany).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports